A detailed history of Freedom Wealth Alliance, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Freedom Wealth Alliance, LLC holds 3,043 shares of ABBV stock, worth $613,164. This represents 0.75% of its overall portfolio holdings.

Number of Shares
3,043
Previous 3,430 11.28%
Holding current value
$613,164
Previous $458 Million 1.01%
% of portfolio
0.75%
Previous 0.64%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 30, 2023

SELL
$133.59 - $154.65 $51,699 - $59,849
-387 Reduced 11.28%
3,043 $454 Million
Q2 2023

Jul 17, 2023

BUY
$132.51 - $164.9 $39,885 - $49,634
301 Added 9.62%
3,430 $458 Million
Q1 2023

Apr 25, 2023

BUY
$144.61 - $166.54 $578 - $666
4 Added 0.13%
3,129 $499 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $432,218 - $518,343
3,125 New
3,125 $505 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $356B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Freedom Wealth Alliance, LLC Portfolio

Follow Freedom Wealth Alliance, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Freedom Wealth Alliance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Freedom Wealth Alliance, LLC with notifications on news.